Serotonin–Norepinephrine Reuptake Inhibitors (SNRI)

3-(Dimethylamino)-1-(2-thienyl)propan-1-ol is an organic compound that is used as a chiral building block in the synthesis of drugs. It is not currently used in any known drug, but it has been shown to be racemized at high temperatures. 3-(Dimethylamino)-1-(2-thienyl)propan-1-ol is also a byproduct of pollution and can be found in the environment where it may be degraded by bacteria.

Duloxetine is an inhibitor of serotonin-norepinephrine reuptake(Ki of 4.6 nM),with treatment of major depressive disorder and generalized anxiety disorder.

4-Methoxy-N,N-dimethylphenethylamine is a natural product that has been shown to inhibit the transfer of bacteria from the environment to food. It also has regulatory properties and can be used as a supplement in dietary drinks. 4-Methoxy-N,N-dimethylphenethylamine is an alkaloidal extract and has been shown to have antibacterial activity against Escherichia coli, Salmonella enterica, and Listeria monocytogenes. This compound was also found to have diffraction properties, which are related to its ability to bind DNA in bacterial cells.

3-(Dimethylamino)-1-(3-thienyl)propan-1-ol (DMAT) is an impurity that was identified in a drug product and that is not found in the natural form. DMAT is an intermediate of the synthesis of DMH, which is used as a research and development tool. DMAT has been shown to be metabolized by cytochrome P450 enzymes and other oxidative reactions, such as oxidation by cytochrome P450 enzymes or conjugation with glucuronic acid. DMAT also binds to markers expressed at high levels in Mycobacterium tuberculosis strains (e.g., ESX-1 secretion system protein) and inhibits cell growth in culture.

Milnacipran, an SNRI with 85% bioavailability, treats fibromyalgia and is well absorbed orally.